These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3770069)

  • 1. Pharmacokinetics of cimetidine after subchronic administration.
    Chin TW; Spino M; MacLeod SM; Mahon WA; Soldin SJ
    Eur J Clin Pharmacol; 1986; 30(6):741-4. PubMed ID: 3770069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR; Santos RM; Werneck E; Andrade GN
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine pharmacokinetics and dosage requirements in children.
    Somogyi A; Becker M; Gugler R
    Eur J Pediatr; 1985 May; 144(1):72-6. PubMed ID: 4018106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers.
    Youlten L
    J Pharm Pharmacol; 2004 Feb; 56(2):169-75. PubMed ID: 15005875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of cimetidine in Zollinger-Ellison syndrome.
    Ziemniak JA; Madura M; Adamonis AJ; Olinger EJ; Dreyer M; Schentag JJ
    Dig Dis Sci; 1983 Nov; 28(11):976-80. PubMed ID: 6628158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
    Ziemniak JA; Assael BM; Padoan R; Schentag JJ
    Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene.
    Muirhead MR; Somogyi AA; Rolan PE; Bochner F
    Clin Pharmacol Ther; 1986 Oct; 40(4):400-7. PubMed ID: 3757403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine disposition in obesity.
    Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
    Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cimetidine dose timing on oral propranolol kinetics in adults.
    Asgharnejad M; Powell JR; Donn KH; Danis M
    J Clin Pharmacol; 1988 Apr; 28(4):339-43. PubMed ID: 3392231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and metabolism of cimetidine in neonates.
    Ziemniak JA; Wynn RJ; Aranda JV; Zarowitz BJ; Schentag JJ
    Dev Pharmacol Ther; 1984; 7(1):30-8. PubMed ID: 6697868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.